Old Web
English
Sign In
Acemap
>
Paper
>
Abciximab with reduced heparin dosing during coronary intervention Final results of the EPILOG trial
Abciximab with reduced heparin dosing during coronary intervention Final results of the EPILOG trial
1997
A.M. Lincoff
James E. Tcheng
R. M. Califf
Catherine F. Cabot
D. P. Milker
Joan E. Booth
E. A. Montague
Keaven M. Anderson
E. J. Topol
Keywords:
Anesthesia
Abciximab
Dosing
Heparin
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]